JULIE BRESNAHAN: Open Payments
NPI 1881311009 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,366 in 105 payments from 23 companies in 2025. Trend: 2023 $954 · 2024 $1,064 · 2025 $2,366
Food & beverage: $2,306Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $545 |
| GENZYME CORPORATION | 13 | $329 |
| Electromed, Inc. | 6 | $210 |
| Regeneron Healthcare Solutions, Inc. | 7 | $195 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $148 |
| United Therapeutics Corporation | 7 | $140 |
| Viatris Specialty LLC | 11 | $137 |
| Insmed, Inc. | 5 | $108 |
| Grifols USA, LLC | 5 | $106 |
| GlaxoSmithKline, LLC. | 5 | $85 |
Products named: DUPIXENT, SMARTVEST, AIRSUPRA, TEZSPIRE, FASENRA, Tyvaso, YUPELRI, Arikayce.
Industry payments across MO — which companies pay providers there.
